The maker of Crestor, another big multinational, AstraZeneca, accused Pfizer of "serious misconduct" according to the code of conduct reports released by Medicines Australia yesterday. "AstraZeneca stated a number of geographically dispersed Pfizer representatives had directed negative and false representations regarding the renal safety profile of Crestor to health-care professionals across NSW and Queensland," the Medicines Australia document states. "AstraZeneca also alleged that whilst Pfizer had given undertakings to cease the conduct and prevent the alleged behaviour from continuing, Pfizer has not corrected the alleged damage that has already occurred to industry stakeholders, including healthcare professionals." AstraZeneca told the committee that after an allegation in the US that the renal safety of Crestor was unsatisfactory, the US Food and Drug Administration had analysed all the safety data for Crestor and concluded that its safety profile was at least equal to other statins.